CY1107353T1 - Υγρο παρασκευασμα για την κτηνιατρικη, μεθοδος παρασκευης και χρησιμοποιησης αυτου - Google Patents

Υγρο παρασκευασμα για την κτηνιατρικη, μεθοδος παρασκευης και χρησιμοποιησης αυτου

Info

Publication number
CY1107353T1
CY1107353T1 CY20081100329T CY081100329T CY1107353T1 CY 1107353 T1 CY1107353 T1 CY 1107353T1 CY 20081100329 T CY20081100329 T CY 20081100329T CY 081100329 T CY081100329 T CY 081100329T CY 1107353 T1 CY1107353 T1 CY 1107353T1
Authority
CY
Cyprus
Prior art keywords
preparation
veterinary
hydroiodide
mixture
treatment
Prior art date
Application number
CY20081100329T
Other languages
English (en)
Inventor
Martin Folger
Bernhard Hassel
Stefan Henke
Dietrich W Janott
Peter Riechel
Original Assignee
Boehringer Ingelheim Vetmedica Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Vetmedica Gmbh filed Critical Boehringer Ingelheim Vetmedica Gmbh
Publication of CY1107353T1 publication Critical patent/CY1107353T1/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/5415—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with carbocyclic ring systems, e.g. phenothiazine, chlorpromazine, piroxicam
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cephalosporin Compounds (AREA)

Abstract

Η εφεύρεση αφορά ένα υγρό παρασκεύασμα για την κτηνιατρική, που περιέχει μελοξικάμη ως πρώτη δραστική ουσία, υδροϊωδική πεναιθαμάτη ως δεύτερη δραστική ουσία και τουλάχιστον ένα διαλυτικό μέσο. Αντικείμενο της εφεύρεσης είναι επίσης μια μέθοδος παρασκευής και χρησιμοποίησης αυτού. Σύμφωνα με την εφεύρεση καθίσταται για πρώτη φορά διαθέσιμο ένα μίγμα μελοξικάμης και υδροϊωδικής πεναιθαμάτης. Η θεραπευτική αγωγή των θηλαστικών με αυτό το μίγμα δεν ήταν έως τώρα δυνατή, επειδή δεν μπορούσε να επιτευχθεί η απαραίτητη για τη χρήση σταθερότητα. Το σύμφωνα με την εφεύρεση παρασκεύασμα παρουσιάζει εντούτοις μια σταθερότητα που εκπλήσσει. Το παρασκεύασμα μπορεί να χρησιμοποιηθεί ως παρασκεύασμα συνδυασμού παράλληλα για τη θεραπευτική αγωγή της μαστίτιδας και των λοιμώξεων της αναπνευστικής οδού.
CY20081100329T 2004-05-19 2008-03-21 Υγρο παρασκευασμα για την κτηνιατρικη, μεθοδος παρασκευης και χρησιμοποιησης αυτου CY1107353T1 (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102004025324A DE102004025324A1 (de) 2004-05-19 2004-05-19 Flüssige Zubereitung für die Veterinärmedizin, Verfahren zu deren Herstellung und deren Verwendung
EP05748118A EP1750700B1 (de) 2004-05-19 2005-05-04 Flüssige zubereitung für die veterinärmedizin; verfahren zu deren herstellung und deren verwendung

Publications (1)

Publication Number Publication Date
CY1107353T1 true CY1107353T1 (el) 2012-12-19

Family

ID=34969447

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20081100329T CY1107353T1 (el) 2004-05-19 2008-03-21 Υγρο παρασκευασμα για την κτηνιατρικη, μεθοδος παρασκευης και χρησιμοποιησης αυτου

Country Status (13)

Country Link
US (1) US20050277634A1 (el)
EP (1) EP1750700B1 (el)
AR (1) AR048965A1 (el)
AT (1) ATE382350T1 (el)
CY (1) CY1107353T1 (el)
DE (2) DE102004025324A1 (el)
DK (1) DK1750700T3 (el)
ES (1) ES2300027T3 (el)
PL (1) PL1750700T3 (el)
PT (1) PT1750700E (el)
SI (1) SI1750700T1 (el)
TW (1) TW200611694A (el)
WO (1) WO2005115386A1 (el)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020035107A1 (en) 2000-06-20 2002-03-21 Stefan Henke Highly concentrated stable meloxicam solutions
DE10161077A1 (de) * 2001-12-12 2003-06-18 Boehringer Ingelheim Vetmed Hochkonzentrierte stabile Meloxicamlösungen zur nadellosen Injektion
US8992980B2 (en) 2002-10-25 2015-03-31 Boehringer Ingelheim Vetmedica Gmbh Water-soluble meloxicam granules
EP1568369A1 (en) * 2004-02-23 2005-08-31 Boehringer Ingelheim Vetmedica Gmbh Use of meloxicam for the treatment of respiratory diseases in pigs
DE102004021281A1 (de) * 2004-04-29 2005-11-24 Boehringer Ingelheim Vetmedica Gmbh Verwendung von Meloxicam-Formulierungen in der Veterinärmedizin
DE102004030409A1 (de) * 2004-06-23 2006-01-26 Boehringer Ingelheim Vetmedica Gmbh Neue Verwendung von Meloxicam in der Veterinärmedizin
NZ567627A (en) * 2005-09-30 2011-08-26 Boehringer Ingelheim Vetmed Granulation process for making a divisible tablet containing meloxicam
PL2121593T3 (pl) 2006-12-10 2015-11-30 Chongxi Yu Przezskórne systemy dostarczania antybiotyków beta-laktamowych
US9969751B2 (en) 2009-06-10 2018-05-15 Techfields Pharma Co., Ltd. High penetration prodrug compositions of antimicrobials and antimicrobial-related compounds
US9101529B2 (en) 2009-10-12 2015-08-11 Boehringer Ingelheim Vetmedica Gmbh Containers for compositions comprising meloxicam
WO2011107150A1 (en) 2010-03-03 2011-09-09 Boehringer Ingelheim Vetmedica Gmbh Use of meloxicam for the long-term treatment of musculoskeletal disorders in cats
US9795568B2 (en) 2010-05-05 2017-10-24 Boehringer Ingelheim Vetmedica Gmbh Low concentration meloxicam tablets
NZ588686A (en) 2011-01-20 2013-07-26 Bayer New Zealand Ltd Injectable composition comprising an NSAID and an antibiotic in a non-aqueous solvent for treating a microbial infection in a mammary gland
KR102309973B1 (ko) 2012-05-16 2021-10-06 테크필즈 파마 코., 엘티디. 폐 병태의 치료를 위한 고침투 전구약물 조성물 및 그의 약제학적 조성물
WO2014014363A1 (en) * 2012-07-17 2014-01-23 Bayer New Zealand Limited Injectable antibiotic formulations and their methods of use

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL59948A0 (en) * 1979-05-21 1980-06-30 Rech Applications Therap Penicillanic acid derivatives,their production and pharmaceutical compositions containing them
IE51846B1 (en) * 1980-11-17 1987-04-15 Leo Pharm Prod Ltd Pharmaceutical preparation for veterinary use and an appliance containing it
DE10030345A1 (de) * 2000-06-20 2002-01-10 Boehringer Ingelheim Vetmed Hochkonzentrierte stabile Meloxicamlösungen
DE10161077A1 (de) * 2001-12-12 2003-06-18 Boehringer Ingelheim Vetmed Hochkonzentrierte stabile Meloxicamlösungen zur nadellosen Injektion

Also Published As

Publication number Publication date
WO2005115386A1 (de) 2005-12-08
ATE382350T1 (de) 2008-01-15
ES2300027T3 (es) 2008-06-01
DE502005002419D1 (de) 2008-02-14
AR048965A1 (es) 2006-06-14
TW200611694A (en) 2006-04-16
US20050277634A1 (en) 2005-12-15
EP1750700B1 (de) 2008-01-02
PL1750700T3 (pl) 2008-06-30
PT1750700E (pt) 2008-01-18
SI1750700T1 (sl) 2008-06-30
DK1750700T3 (da) 2008-02-04
DE102004025324A1 (de) 2005-12-08
EP1750700A1 (de) 2007-02-14

Similar Documents

Publication Publication Date Title
CY1107353T1 (el) Υγρο παρασκευασμα για την κτηνιατρικη, μεθοδος παρασκευης και χρησιμοποιησης αυτου
CY1114363T1 (el) Ανθελμινθικος συνδυασμος
CY1121125T1 (el) Συνθεσεις για τη θεραπευτικη αντιμετωπιση του πονου και/ή της φλεγμονης
CY1110873T1 (el) Σταθεροποιημενα σκευασματα αντισωματων anti-rsv, υγρης μορφης
CY1107975T1 (el) Σπειροκυκλικα παραγωγα κυκλοεξανιου με χημικη συγγενεια προς τον υποδοχεα orl1
CY1106468T1 (el) Υποκατεστημενα παραγωγα κυκλοεξανο-1,4-διαμινης
BR112018003845A2 (pt) auxiliares cirúrgicos com medicamentos afetados por materiais ativadores
CY1111264T1 (el) Στερεο παρασκευασμα που περιλαμβανει αλογλιπτινη και πιογλιταζονη
CR20120255A (es) Derivados de purina o deazapurina útiles para el tratamiento de inter alia infecciones virales
CR7971A (es) Sistema para monitoreo de paciente y suministro de farmaco y metodo de uso
NZ751197A (en) Compounds and methods of treating infections
BRPI0414581C1 (pt) composto, composição farmacêutica compreendendo o referido composto e uso do referido composto
BR112012019101A2 (pt) módulo medicamentoso com botão de uso duplo e sistema de fornecimento de medicamento.
EA201000574A1 (ru) Композиция на основе силиконового геля и лекарственное средство для лечения ран с уменьшенной степенью рубцевания
ECSP21042554A (es) Proteínas f de prefusión del vrs estabilizadas
WO2010059719A3 (en) Dimeric 1-arylpyrazole derivatives
CY1109229T1 (el) Χρηση σπογγοσινης (2-μεθοξυαδενοσινης) για τη θεραπεια πονου, συγκεκριμενα υπερευαισθησιας στο πονο
CL2004000930A1 (es) Compuesto derivado de dihidroquinazolina de formula definida, util para el tratamiento y/o profilaxis de infecciones virales; composicion farmaceutica que comprende al compuesto y uso del compuesto en la preparacion de medicamentos.
CY1108797T1 (el) Α-κρυσταλλικη μορφη του ρανελικου στροντιου, μεθοδος παρασκευης της και φαρμακευτικες συνθεσεις που την περιεχουν
BR112023022836A2 (pt) Agonistas de receptores de glp-1 benzimidazoíla, composições farmacêuticas que compreendem os mesmos e métodos para seu uso
BR112017004153A2 (pt) métodos para tratamento de infecções por protozoários
EA201992272A1 (ru) Ацилированное инсулиновое соединение
CY1116831T1 (el) ΧΡΗΣΗ 24-norUDCA
CO2021011023A2 (es) Compuesto heterocíclico, composición farmacéutica que lo comprende, método para su preparación, y uso de estos
ATE526012T1 (de) Pharmazeutische formulierungen von meloxicam